Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Krt14 and Krt15 differentially regulate regenerative properties and differentiation potential of airway basal cells
Vitaly Ievlev, … , John F. Engelhardt, Kalpaj R. Parekh
Vitaly Ievlev, … , John F. Engelhardt, Kalpaj R. Parekh
Published December 13, 2022
Citation Information: JCI Insight. 2023;8(2):e162041. https://doi.org/10.1172/jci.insight.162041.
View: Text | PDF
Research Article Pulmonology Stem cells

Krt14 and Krt15 differentially regulate regenerative properties and differentiation potential of airway basal cells

  • Text
  • PDF
Abstract

Keratin expression dynamically changes in airway basal cells (BCs) after acute and chronic injury, yet the functional consequences of these changes on BC behavior remain unknown. In bronchiolitis obliterans (BO) after lung transplantation, BC clonogenicity declines, which is associated with a switch from keratin15 (Krt15) to keratin14 (Krt14). We investigated these keratins’ roles using Crispr-KO in vitro and in vivo and found that Krt14-KO and Krt15-KO produce contrasting phenotypes in terms of differentiation and clonogenicity. Primary mouse Krt14-KO BCs did not differentiate into club and ciliated cells but had enhanced clonogenicity. By contrast, Krt15-KO did not alter BC differentiation but impaired clonogenicity in vitro and reduced the number of label-retaining BCs in vivo after injury. Krt14, but not Krt15, bound the tumor suppressor stratifin (Sfn). Disruption of Krt14, but not of Krt15, reduced Sfn protein abundance and increased expression of the oncogene dNp63a during BC differentiation, whereas dNp63a levels were reduced in Krt15-KO BCs. Overall, the phenotype of Krt15-KO BCs contrasts with Krt14-KO phenotype and resembles the phenotype in BO with decreased clonogenicity, increased Krt14, and decreased dNp63a expression. This work demonstrates that Krt14 and Krt15 functionally regulate BC behavior, which is relevant in chronic disease states like BO.

Authors

Vitaly Ievlev, Thomas J. Lynch, Kyle W. Freischlag, Caitlyn B. Gries, Anit Shah, Albert C. Pai, Bethany A. Ahlers, Soo Park, John F. Engelhardt, Kalpaj R. Parekh

×

Figure 1

Dynamic changes in Krt14 and Krt15 expression after an injury and in vitro.

Options: View larger image (or click on image) Download as PowerPoint
Dynamic changes in Krt14 and Krt15 expression after an injury and in vit...
(A–C) Immunofluorescence staining of a cartilaginous ferret airway from a healthy control ferret (A), a ferret 3 days after polidocanol injury (B), and a ferret that developed a form of CLAD after lung transplantation (C). (D–F) Quantified protein expression of p63 (D), Krt14 (E), and Krt15 (F) in large airways. (G and H) Murine SAE cells show a different basal keratin profile on passage 1 (G) compared with passage 5 (H). (I and J) Quantification of Krt14 and Krt15 abundance in primary SAE from mice (I) and ferrets (J) grown with dual SMAD inhibition in SAGM and Pneumacult-Ex Plus (PnEx+), respectively. Graphs show mean data ± SEM; n = 6 ferrets (D–F) or n ≥ 3 cell pools (I and J). Significance was determined by 1-way ANOVA and Tukey multiple comparison test (D–F) or by 2-way ANOVA and Sidak multiple comparison test (I and J). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Scale bars: 50 μm in A–C and 20 μm in G and H.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts